HEIDI HUNTER, M.B.A.

Heidi Hunter has over 25 years of experience in biotech across the pharmaceutical value chain, from clinical and commercial development through to launch execution. She is formerly President at Cardinal Health, where she lead the Specialty Solutions Businesses. Prior to Cardinal Health, Ms. Hunter was Senior Vice President of the Global Immunology Business Unit at UCB in Brussels. She has also held leadership positions at Boehringer Ingelheim as Senior Vice President and General Manager in its Global Biosimilars Business, and at IQVIA as Vice President of Global Business Partnerships Commercial Solutions. Ms. Hunter also held senior leadership positions in commercial and strategic marketing for biologics and oncology at Centocor, a J&J company. She also led women’s health and oncology business at Wyeth (today part of Pfizer) in the U.S. and women’s health at Novo Nordisk in Denmark. Early in Ms. Hunter’s career, she led sales and marketing at Wyeth and led Neurology at Ciba-Geigy in Switzerland (today part of Novartis). She is currently on the board of Vicore Pharma, Bavarian Nordic and IO Biotech. Ms. Hunter earned B.A. from The University of Michigan and her M.B.A. from The University of Chicago.